GSK lifts long-term outlook following launch of blockbuster vaccine in 2023
The FTSE-100 drugmaker predicted new drug and vaccine launches will see its annual sales hit £38 billion by 2031
Source: marketwatch.com
Page 15 - Immunizations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Immunizations Today - Breaking & Trending Today
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales -- 2nd Update
By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the...
Source: marketwatch.com
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales -- Update
By Joe Hoppe GSK expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the...
Source: marketwatch.com
GSK Reports Earnings Wednesday. Here's What to Expect.
GSK reports earnings Wednesday in a week week for pharmaceutical companies’ results. A large focus will be its RSV vaccine, Arexy.
Source: marketwatch.com
New pediatric immunization guidelines take a jab at vaccine hesitancy
It happens every year around this time: The Centers for Disease Control and Prevention releases the new year's immunization schedules, which describe when and how vaccines should be given.
Source: gazettextra.com